Special Issue "Implications of Antibiotics Use during the COVID-19 Pandemic: Present and Future"
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 18742
Interests: virology; clinical microbiology; tropical and emergent pathogens; molecular epidemiology; COVID-19; antimicrobial stedwarship in COVID-19
Special Issues, Collections and Topics in MDPI journals
Special Issue in Vaccines: Emerging and Reemerging Viral Infection, Immunopathogenesis and Diagnosis of Viral Infection, and Development of the Novel Antiviral Strategies
Special Issue in Antibiotics: Antibiotics and Antimicrobials in Monkeypox and Other Emerging and Reemerging Zoonotic Diseases
The coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), has had a global impact, leading to more than 120 million cases confirmed and more than 2.6 million deaths reported as of March 16, 2021. The implications on the management of patients including multiple aspects, such as the repurposing of antimicrobials, as in the case of antibiotics, but also the therapy of bacterial secondary infections and coinfections, have been matters of concern since the beginning of the pandemic. This Special Issue will present emerging concepts regarding the implications of antibiotics use during the COVID-19 pandemic, searching for further understanding of the current evidence and future scenarios.
Prof. Dr. Alfonso J. Rodriguez-Morales
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- secondary infection